{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:34:43Z","timestamp":1793388883740,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003398","name":"Shanxi Scholarship Council of China","doi-asserted-by":"publisher","award":["2021-036"],"award-info":[{"award-number":["2021-036"]}],"id":[{"id":"10.13039\/501100003398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.virol.2025.110540","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T02:36:30Z","timestamp":1744425390000},"page":"110540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main protease activity"],"prefix":"10.1016","volume":"608","author":[{"given":"Le","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-9107","authenticated-orcid":false,"given":"Cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2025.110540_bib1","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2211688","article-title":"Orthogonal dual reporter-based gain-of-signal assay for probing SARS-CoV-2 3CL protease activity in living cells: inhibitor identification and mutation investigation","volume":"12","author":"Bei","year":"2023","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virol.2025.110540_bib2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.chembiol.2004.08.011","article-title":"High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase","volume":"11","author":"Blanchard","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.virol.2025.110540_bib3","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1038\/s41467-022-31570-3","article-title":"Low-cost anti-mycobacterial drug discovery using engineered E. coli","volume":"13","author":"Bongaerts","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2025.110540_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1021\/acsbiomedchemau.2c00034","article-title":"Dual-reporter system for real-time monitoring of SARS-CoV-2 main protease activity in live cells enables identification of an allosteric inhibition path","volume":"2","author":"Bram","year":"2022","journal-title":"ACS Bio Med. Chem. Au"},{"key":"10.1016\/j.virol.2025.110540_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027228","article-title":"Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses","volume":"6","author":"Chuck","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2025.110540_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/biom11040607","article-title":"SARS-CoV-2 M(pro): a potential target for peptidomimetics and small-molecule inhibitors","volume":"11","author":"Citarella","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.virol.2025.110540_bib7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.abb4489","article-title":"Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virol.2025.110540_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105183","article-title":"A fluorescence-based, gain-of-signal, live cell system to evaluate SARS-CoV-2 main protease inhibition","volume":"195","author":"Dey-Rao","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2025.110540_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41586-023-06609-0","article-title":"Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir","volume":"622","author":"Duan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.virol.2025.110540_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acschembio.2c00735","article-title":"Discovery of all-d-peptide inhibitors of SARS-CoV-2 3C-like protease","volume":"18","author":"Eberle","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.virol.2025.110540_bib11","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1073\/pnas.89.15.7017","article-title":"Phycocyanin alpha-subunit phycocyanobilin lyase","volume":"89","author":"Fairchild","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.virol.2025.110540_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1021\/cb8000414","article-title":"Novel genetically encoded biosensors using firefly luciferase","volume":"3","author":"Fan","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.virol.2025.110540_bib13","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1248\/bpb.b24-00369","article-title":"Sunflower trypsin monocyclic inhibitor selected for the main protease of SARS-CoV-2 by phage display","volume":"47","author":"Ferreira","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.virol.2025.110540_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1021\/acssynbio.3c00446","article-title":"The SARS-CoV-2 M(pro) dimer-based screening system: a synthetic biology tool for identifying compounds with dimerization inhibitory potential","volume":"13","author":"Giri-Rachman","year":"2024","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.virol.2025.110540_bib15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virol.2025.110540_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s42003-022-03277-0","article-title":"A VSV-based assay quantifies coronavirus Mpro\/3CLpro\/Nsp5 main protease activity and chemical inhibition","volume":"5","author":"Heilmann","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.virol.2025.110540_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq7360","article-title":"SARS-CoV-2 3CL(pro) mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376","volume":"15","author":"Heilmann","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2025.110540_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02559-21","article-title":"BRET-based self-cleaving biosensors for SARS-CoV-2 3CLpro inhibitor discovery","volume":"10","author":"Hou","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.virol.2025.110540_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bbamcr.2018.11.008","article-title":"Bright near-infrared fluorescence bio-labeling with a biliprotein triad","volume":"1866","author":"Hou","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.virol.2025.110540_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virol.2025.110540_bib21","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1039\/D1SC06750H","article-title":"Antiviral cyclic peptides targeting the main protease of SARS-CoV-2","volume":"13","author":"Johansen-Leete","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.virol.2025.110540_bib22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.pathol.2020.09.006","article-title":"Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent","volume":"52","author":"Kaufer","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.virol.2025.110540_bib23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.str.2022.01.007","article-title":"Crystal structure and molecular mechanism of an E\/F type bilin lyase-isomerase","volume":"30","author":"Kumarapperuma","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.virol.2025.110540_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00597-23","article-title":"A low-background, fluorescent assay to evaluate inhibitors of diverse viral proteases","volume":"97","author":"Leonard","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110540_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.virol.2025.110540_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/bulcsj\/uoae018","article-title":"Cyclic \u03b2(2,3)-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease","volume":"97","author":"Miura","year":"2024","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.virol.2025.110540_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00784-22","article-title":"Gain-of-Signal assays for probing inhibition of SARS-CoV-2 M(pro)\/3CL(pro) in living cells","volume":"13","author":"Moghadasi","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.virol.2025.110540_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade8778","article-title":"Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors","volume":"9","author":"Moghadasi","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virol.2025.110540_bib29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/22221751.2020.1870414","article-title":"SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species","volume":"10","author":"Moustaqil","year":"2021","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virol.2025.110540_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2021.01.010","article-title":"Detecting SARS-CoV-2 3CLpro expression and activity using a polyclonal antiserum and a luciferase-based biosensor","volume":"556","author":"O'Brien","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.virol.2025.110540_bib31","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.virol.2025.110540_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/JVI.01715-20","article-title":"A versatile reporter system to monitor virus-infected cells and its application to dengue virus and SARS-CoV-2","volume":"95","author":"Pahmeier","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110540_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/v13020173","article-title":"Development of a cell-based luciferase complementation assay for identification of SARS-CoV-2 3CL(pro) inhibitors","volume":"13","author":"Rawson","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2025.110540_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02374-20","article-title":"Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity","volume":"95","author":"Resnick","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2025.110540_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2022.106208","article-title":"Optimization of the expression of the main protease from SARS-CoV-2","volume":"203","author":"Rong","year":"2023","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.virol.2025.110540_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41589-020-00689-z","article-title":"SARS-CoV-2 M(pro) inhibitors and activity-based probes for patient-sample imaging","volume":"17","author":"Rut","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.virol.2025.110540_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104779","article-title":"3CL(pro) inhibitors as a potential therapeutic option for COVID-19: available evidence and ongoing clinical trials","volume":"156","author":"Sisay","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.virol.2025.110540_bib38","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acssensors.0c02482","article-title":"Engineering bacteria to monitor the bleeding of animals using far-red fluorescence","volume":"6","author":"Tan","year":"2021","journal-title":"ACS Sens."},{"key":"10.1016\/j.virol.2025.110540_bib39","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","article-title":"Discovery of S-217622, a noncovalent oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19","volume":"65","author":"Unoh","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virol.2025.110540_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-022-04856-1","article-title":"Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2","volume":"607","author":"Uraki","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.virol.2025.110540_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71305-6","article-title":"A Gaussia luciferase reporter assay for the evaluation of coronavirus Nsp5\/3CLpro activity","volume":"14","author":"Vlachou","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2025.110540_bib42","first-page":"149","article-title":"Peptidoglycan structure and architecture","volume":"32","author":"Vollmer","year":"2008","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"key":"10.1016\/j.virol.2025.110540_bib43","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1038\/s41467-020-18096-2","article-title":"Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"11","author":"Vuong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2025.110540_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virol.2025.110540_bib45","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1021\/jacs.8b13042","article-title":"Designing a green fluorogenic protease reporter by flipping a beta strand of GFP for imaging apoptosis in animals","volume":"141","author":"Zhang","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.virol.2025.110540_bib46","doi-asserted-by":"crossref","first-page":"13170","DOI":"10.1073\/pnas.1715495114","article-title":"Structures and enzymatic mechanisms of phycobiliprotein lyases CpcE\/F and PecE\/F","volume":"114","author":"Zhao","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225001539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682225001539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T01:56:52Z","timestamp":1762221412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682225001539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":46,"alternative-id":["S0042682225001539"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2025.110540","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main protease activity","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2025.110540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110540"}}